Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UScellular (United States Cellular Corporation) is a major American wireless telecommunications carrier, historically the fifth-largest in the United States. While primarily a telecommunications provider, the company offers specialized "Internet of Medical Things" (IoMT) and private 5G networking solutions tailored for the healthcare sector, including telehealth connectivity and hospital asset tracking. In 2024, T-Mobile US announced the acquisition of UScellular's wireless operations and select spectrum assets for $4.4 billion, a deal that closed in August 2025, after which the remaining company was renamed Array Digital Infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U.S. Cellular.